{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T20:09:27Z","timestamp":1781381367213,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81774005"],"award-info":[{"award-number":["81774005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State Revenue for the Development of Local Colleges","award":["2016-67"],"award-info":[{"award-number":["2016-67"]}]},{"name":"Chongqing Social Undertaking and Livelihood Security Project","award":["cstc2017shmsA130079"],"award-info":[{"award-number":["cstc2017shmsA130079"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jep.2018.11.045","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T12:26:36Z","timestamp":1544012796000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L."],"prefix":"10.1016","volume":"232","author":[{"given":"Liqing","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2018.11.045_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0092-8674(00)81318-5","article-title":"NF-\u03baB: ten years after","volume":"87","author":"Baeuerle","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jep.2018.11.045_bib2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","article-title":"The development of human benign prostatic hyperplasia with age","volume":"132","author":"Berry","year":"1984","journal-title":"J. Urol."},{"key":"10.1016\/j.jep.2018.11.045_bib3","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.eursup.2009.11.002","article-title":"Benign prostatic hyperplasia and its aetiologies","volume":"8","author":"Briganti","year":"2009","journal-title":"Eur. Urol. Suppl."},{"key":"10.1016\/j.jep.2018.11.045_bib4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jep.2016.10.036","article-title":"Uvaria rufa Blume attenuates benign prostatic hyperplasia via inhibiting 5\u03b1-reductase and enhancing antioxidant status","volume":"194","author":"Buncharoen","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2018.11.045_bib5","first-page":"3323","article-title":"Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease","volume":"52","author":"Carter","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.jep.2018.11.045_bib6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2011.11.013","article-title":"The correlation between metabolic syndrome and prostatic diseases","volume":"61","author":"De Nunzio","year":"2012","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jep.2018.11.045_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2011.03.055","article-title":"The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation","volume":"60","author":"De Nunzio","year":"2011","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jep.2018.11.045_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/10286020.2016.1194833","article-title":"Renchangianins F and G: two new sesquiterpenoids from Kadsura renchangiana","volume":"19","author":"Deng","year":"2017","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.jep.2018.11.045_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2006-957624","article-title":"Inhibition of 5\u03b1-reductase and aromatase by the ellagitannins oenothein A and oenothein B from Epilobium species","volume":"63","author":"Ducrey","year":"1997","journal-title":"Planta Med."},{"key":"10.1016\/j.jep.2018.11.045_bib10","series-title":"Flora of China","first-page":"409","author":"Editorial Committee of Flora of China","year":"2009"},{"key":"10.1016\/j.jep.2018.11.045_bib11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jep.2014.08.036","article-title":"Phytochemistry, pharmacology and traditional uses of different Epilobium species (Onagraceae): a review","volume":"156","author":"Granica","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2018.11.045_bib12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.phymed.2006.09.005","article-title":"Down-regulation of prostate specific antigen in LNCaP cells by flavonoids from the pollen of Brassica napus L","volume":"14","author":"Han","year":"2007","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2018.11.045_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0378-8741(96)01498-5","article-title":"Studies of Epilobium angustifolium extracts on growth of accessory sexual organs in rats","volume":"55","author":"Hiermann","year":"1997","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2018.11.045_bib14","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jep.2013.05.023","article-title":"The suppressive effects of Saposhnikovia divaricata (Fangfeng) chromone extract on rheumatoid arthritis via inhibition of nuclear factor-\u03baB and mitogen activated proteinkinases activation on collagen-induced arthritis model","volume":"148","author":"Kong","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2018.11.045_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1081-1206(10)63052-9","article-title":"Interleukin-10: biology, role in inflammation and autoimmunity","volume":"79","author":"Lalani","year":"1997","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.jep.2018.11.045_bib16","doi-asserted-by":"crossref","first-page":"62996","DOI":"10.1039\/C4RA10968F","article-title":"Potential of grape seed-derived polyphenols extract for protection against testosterone-induced benign prostatic hyperplasia in castrated rats","volume":"4","author":"Lei","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.jep.2018.11.045_bib17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1021\/np960231c","article-title":"Determination of oenothein B as the active 5-alpha-reductase-inhibiting principle of the folk medicine Epilobium parviflorum","volume":"5","author":"Lesuisse","year":"1996","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.jep.2018.11.045_bib18","first-page":"408","article-title":"Chamerilactone A: one new isocoumarin isolated from Chamerion angustifolium","volume":"51","author":"Liu","year":"2016","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.jep.2018.11.045_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.diff.2011.06.001","article-title":"Role of interleukins, IGF and stem cells in BPH","volume":"82","author":"McLaren","year":"2011","journal-title":"Differentiation"},{"key":"10.1016\/j.jep.2018.11.045_bib20","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/bju.12452","article-title":"Inflammation and prostate cancer: the role of interleukin 6 (IL-6)","volume":"113","author":"Nguyen","year":"2014","journal-title":"BJU Int."},{"key":"10.1016\/j.jep.2018.11.045_bib21","doi-asserted-by":"crossref","first-page":"e1459","DOI":"10.1016\/S1569-9056(15)30500-5","article-title":"Role of prostatic inflammation in the clinical presentation of benign prostatic hyperplasia","volume":"14","author":"Nickel","year":"2015","journal-title":"Eur. Urol. Suppl."},{"key":"10.1016\/j.jep.2018.11.045_bib22","first-page":"949","article-title":"Phytotherapy of benign prostatic hyperplasia","volume":"28","author":"Pagano","year":"2014","journal-title":"Rev. Phyther. Res."},{"key":"10.1016\/j.jep.2018.11.045_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.tvir.2012.10.001","article-title":"Benign prostatic hyperplasia: a brief overview of pathogenesis, diagnosis, and therapy","volume":"15","author":"Priest","year":"2012","journal-title":"Tech. Vasc. Interv. Radiol."},{"key":"10.1016\/j.jep.2018.11.045_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.eursup.2013.08.001","article-title":"The link between benign prostatic hyperplasia and inflammation","volume":"12","author":"Ribal","year":"2013","journal-title":"Eur. Urol. Suppl."},{"key":"10.1016\/j.jep.2018.11.045_bib25","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.eursup.2009.11.004","article-title":"Should we investigate prostatic inflammation for the management of benign prostatic hyperplasia?","volume":"8","author":"Robert","year":"2009","journal-title":"Eur. Urol. Suppl."},{"key":"10.1016\/j.jep.2018.11.045_bib26","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.LAB.0000081388.40145.65","article-title":"Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue","volume":"83","author":"Steiner","year":"2003","journal-title":"Lab. Investig."},{"key":"10.1016\/j.jep.2018.11.045_bib27","first-page":"314","article-title":"Benign prostatic hyperplasia","volume":"32","author":"Thiruchelvam","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.jep.2018.11.045_bib28","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/ptr.6072","article-title":"Epilobium spp: pharmacology and Phytochemistry.","volume":"32","author":"Vitalone","year":"2018","journal-title":"Phyther. Res."},{"key":"10.1016\/j.jep.2018.11.045_bib29","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.mehy.2007.08.022","article-title":"Chronic inflammation in benign prostatic hyperplasia: implications for therapy","volume":"70","author":"Wang","year":"2008","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jep.2018.11.045_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.toxlet.2016.11.011","article-title":"The anti-hyperplasia, anti-oxidative and anti-inflammatory properties of Qing Ye Dan and swertiamarin in testosterone-induced benign prostatic hyperplasia in rats","volume":"265","author":"Wu","year":"2017","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jep.2018.11.045_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jep.2014.09.025","article-title":"Abacopteris penangiana exerts testosterone-induced benign prostatic hyperplasia protective effect through regulating inflammatory responses, reducing oxidative stress and anti-proliferative","volume":"157","author":"Yang","year":"2014","journal-title":"J. Ethnopharmacol."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874118328782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874118328782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T06:40:37Z","timestamp":1565246437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874118328782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":31,"alternative-id":["S0378874118328782"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2018.11.045","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2018.11.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}